Purchases and Sales Made in Q4 2022 in Cytom X Therapeutics, Inc. (CTMX)
This table provides information about the institutional ownership of Cytom X Therapeutics, Inc. (CTMX) during Q4 2022. The information is specifically focused on institutions that hold shares of CytomX Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Newtyn Management, LLC
New York, NY |
SELL
|
- |
-230K- 28.75% |
$274K - $439K
|
570K
$479K
|
|
|
Feb 14, 2023
Q4 2022
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-432K- 39.52% |
$515K - $826K
|
662K
$556K
|
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-465K- 25.74% |
$553K - $888K
|
1.34M
$1.13M
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-499K- 27.75% |
$594K - $954K
|
1.3M
$1.09M
|
|
|
Feb 13, 2023
Q4 2022
|
Platinum Investment Management LTD
Sydney Australia 2000, C3 |
SELL
|
- |
-594K- 48.29% |
$707K - $1.13M
|
636K
$534K
|